Search
for
Sort by
Research 661–690 of 1000+
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Comparison of autologous platelet concentrates and topical steroids on oral lichen planus: a systematic review and meta-analysis
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Janus Kinase inhibitors in dermatology: a review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- New therapies for alopecia areata
- Micro-Injury Induces Hair Regeneration and Vitiligo Repigmentation Through Wnt/ β-Catenin Pathway
- The role of janus kinases in the treatment of autoimmune skin diseases
- Treatments for alopecia areata: a network meta-analysis
- Characterization of Primary Cilia and Intraflagellar Transport 20 in the Epidermis
- Pharmacological Treatment of Alopecia
- Diuretics
- Alopecia Areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Melanocytes and Vitiligo (and Hair Graying)
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Psikonöroimmünoloji ve Multifaktöryel Psikodermatolojik Hastalıklar
- Primary cicatricial alopecias
- Cutaneous drug reactions
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
- Engineering immune-competent hair follicle microphysiological systems: from organoid assembly to dynamic immune modelling
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Skin aging: mechanisms, evaluation, and rejuvenation